Australian Clinical Labs Ltd 2024 AR2
The report outlines Australian Clinical Labs Limited's financial and operational performance for the fiscal year ended June 30, 2024. Key highlights include generating $696.4 million in annual revenue and achieving an underlying EBIT of $62.6 million. On the sustainability front, the company reduced its carbon emissions to 1.25 kg CO2 per episode, expanded its hybrid and electric vehicle fleet to 98 cars, and decreased packaging waste by over 26 tonnes. Additionally, the company improved its gender diversity, achieving 43% female representation on the Board and 80% female representation among total staff.
Company: Australian Clinical Labs Ltd
Sector: Health Care
Country: Australia
Year: 2024
Type: AR2
Pages: 122
Back to company
Australian Clinical Labs Ltd
Annual Report
The report outlines Australian Clinical Labs Limited's financial and operational performance for the fiscal year ended June 30, 2024. Key highlights include generating $696.4 million in annual revenue and achieving an underlying EBIT of $62.6 million. On the sustainability front, the company reduced its carbon emissions to 1.25 kg CO2 per episode, expanded its hybrid and electric vehicle fleet to 98 cars, and decreased packaging waste by over 26 tonnes. Additionally, the company improved its gender diversity, achieving 43% female representation on the Board and 80% female representation among total staff.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jul 1, 2023 - Jun 30, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees